Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer.

Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, Sekido Y, Minna JD, Sone S, Yokota J.

Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12269-74. Epub 2002 Sep 3.

PMID:
12209013
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer.

Yanaihara N, Nishioka M, Kohno T, Otsuka A, Okamoto A, Ochiai K, Tanaka T, Yokota J.

Int J Cancer. 2004 Oct 20;112(1):150-4.

PMID:
15305387
[PubMed - indexed for MEDLINE]
3.

Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells.

Tani M, Ito J, Nishioka M, Kohno T, Tachibana K, Shiraishi M, Takenoshita S, Yokota J.

Genes Chromosomes Cancer. 2004 Jun;40(2):146-51.

PMID:
15101048
[PubMed - indexed for MEDLINE]
4.

Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer.

Nakano T, Tani M, Nishioka M, Kohno T, Otsuka A, Ohwada S, Yokota J.

Genes Chromosomes Cancer. 2005 Jun;43(2):162-71.

PMID:
15751041
[PubMed - indexed for MEDLINE]
5.

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F.

Oncogene. 2001 Mar 22;20(12):1509-18.

PMID:
11313894
[PubMed - indexed for MEDLINE]
Free Article
6.

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.

Nat Genet. 2000 Jul;25(3):315-9.

PMID:
10888881
[PubMed - indexed for MEDLINE]
7.

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.

Oncogene. 2003 Mar 13;22(10):1580-8.

PMID:
12629521
[PubMed - indexed for MEDLINE]
9.

SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.

Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, Maher ER, Latif F.

Cancer Res. 2002 Oct 15;62(20):5874-80.

PMID:
12384551
[PubMed - indexed for MEDLINE]
Free Article
10.

Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32.

Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y.

Genes Chromosomes Cancer. 2000 Feb;27(2):169-76.

PMID:
10612805
[PubMed - indexed for MEDLINE]
11.

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.

Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.

Cancer Res. 2001 Jun 1;61(11):4556-60.

PMID:
11389090
[PubMed - indexed for MEDLINE]
Free Article
12.

Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.

Nishioka M, Kohno T, Takahashi M, Niki T, Yamada T, Sone S, Yokota J.

Oncogene. 2000 Dec 14;19(54):6251-60.

PMID:
11175339
[PubMed - indexed for MEDLINE]
Free Article
13.

Differential inactivation of caspase-8 in lung cancers.

Shivapurkar N, Toyooka S, Eby MT, Huang CX, Sathyanarayana UG, Cunningham HT, Reddy JL, Brambilla E, Takahashi T, Minna JD, Chaudhary PM, Gazdar AF.

Cancer Biol Ther. 2002 Jan-Feb;1(1):65-9.

PMID:
12170765
[PubMed - indexed for MEDLINE]
Free Article
14.

Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.

Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y.

Int J Cancer. 2003 Oct 20;107(1):53-9.

PMID:
12925956
[PubMed - indexed for MEDLINE]
15.

Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.

Imoto I, Izumi H, Yokoi S, Hosoda H, Shibata T, Hosoda F, Ohki M, Hirohashi S, Inazawa J.

Cancer Res. 2006 May 1;66(9):4617-26.

PMID:
16651412
[PubMed - indexed for MEDLINE]
Free Article
16.

Genetic alterations responsible for metastatic phenotypes of lung cancer cells.

Yokota J, Nishioka M, Tani M, Kohno T.

Clin Exp Metastasis. 2003;20(3):189-93. Review.

PMID:
12741677
[PubMed - indexed for MEDLINE]
17.

Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.

Wu W, Kemp BL, Proctor ML, Gazdar AF, Minna JD, Hong WK, Mao L.

Cancer Res. 1999 Apr 15;59(8):1846-51.

PMID:
10213490
[PubMed - indexed for MEDLINE]
Free Article
18.

Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.

Dallol A, Forgacs E, Martinez A, Sekido Y, Walker R, Kishida T, Rabbitts P, Maher ER, Minna JD, Latif F.

Oncogene. 2002 May 2;21(19):3020-8.

PMID:
12082532
[PubMed - indexed for MEDLINE]
Free Article
19.

Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.

Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF.

Int J Cancer. 2003 Aug 20;106(2):198-204.

PMID:
12800194
[PubMed - indexed for MEDLINE]
20.

Mutation analysis of the PTEN/MMAC1 gene in lung cancer.

Forgacs E, Biesterveld EJ, Sekido Y, Fong K, Muneer S, Wistuba II, Milchgrub S, Brezinschek R, Virmani A, Gazdar AF, Minna JD.

Oncogene. 1998 Sep 24;17(12):1557-65.

PMID:
9794233
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk